Prognostic factors in localized aggressive non-Hodgkin's lymphoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 26, Issue 1, 2003, Pages 1-5

  Alici, Süleyman ^a,b   Bavbek, Sevil E ^a   Kaytan, Esra ^a   Eralp, Yeşim ^a   Onat, Haluk ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Localized aggressive non Hodgkin's lymphoma; Prognostic factors

Indexed keywords

BETA 2 MICROGLOBULIN; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; LACTATE DEHYDROGENASE; PREDNISOLONE; SERUM ALBUMIN; VINCRISTINE;

ADOLESCENT; ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GENDER; HISTOPATHOLOGY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHOMA, HIGH-GRADE; LYMPHOMA, INTERMEDIATE-GRADE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0037318925     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200302000-00001     Document Type: Article

References (28)

1. Chabner BA, Johnson RE, Devita VT, et al. Sequential staging in non-Hodgkin's lymphoma. Cancer Treat Rep 1977;61:993-997.
2. Chen MG, Prosnitz LR, Gonzales-Serva A, et al. Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma. Cancer 1979;43:1245-1254.
3. Mauch P, Leonard R, Skarin AT, et al. Improved survival following combined radiation therapy and chemotherapy for unfavourable prognosis, stage I and II non-Hodgkin's lymphoma. J Clin Oncol 1985;3:1301-1308.
4. Reddy S, Saxene VS, Pellettiere EV, et al. Early nodal and extranodal non-Hodgkin's lymphoma. Cancer 1977;40:98-104.
5. Oguchi M, Ikeda H, Isobe K, et al. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group. Int J Radiat Oncol Biol Phys 2000;48:161-168.
6. Miller TP, Jones SE. Initial chemotherapy for clinically localized lymphomas of unfavourable histology. Blood 1983;62:413-418.
7. Cabanillas F, Bodey GP, Freireich EJ. Management with chemotherapy only of stages I and II malignant lymphoma of aggressive histologic type. Cancer 1980;46:2356-2359.
8. Bonadonna G, Lattuada A, Monifardini S, et al. Combined radiotherapy-chemotherapy in localised non-Hodgkin's lymphomas: 5 year results of a randomised study. In: Salmon SE, Jones SE, eds. Adjuvant therapy of cancer. New York: Grune and Stratton, 1979:145-153.
9. Landberg TG, Hakansson LG, Moller TR, et al. CVP-remission maintenance in stage I or II non-Hodgkin's lymphoma. Cancer 1979;44:831-838.
10. Van der Maazen RW, Noordijk EM, Thomas J, et al. Combined modality treatment is the treatment of choice for stage I/IE intermediate and high grade non-Hodgkin's lymphomas. Radiother Oncol 1998;49:1-7.
11. Munck JN, Dhermain F, Koscielny S, et al. Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin's lymphomas: long-term results for 96 patients with tumors > 5 cm. Ann Oncol 1996;7:925-931.
12. Fuller LM, Banker FL, Butler JJ, et al. The natural history of non-Hodgkin's lymphoma, stages I and II. Br J Cancer 1975;31:270-285.
13. Vokes EE, Ultmann JE, Golomb HM, et al. Long term survival of patients with localised diffuse histiocytic lymphoma. J Clin Oncol 1985;3:1309-1317.
14. Kushlan P, Coleman CN, Glatstein EJ, et al. Prognostic factors in stage II diffuse histiocytic lymphoma. Proc Am Soc Clin Oncol 1978;19:337.
15. Toonkel LM, Fuller LM, Gample JF, et al. Laparotomy stage I and II non-Hodgkin's lymphomas. Preliminary results of radiotherapy and adjunctive chemotherapy. Cancer 1980;45:249-260.
16. The international Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987-994.
17. Miller AB, Hoogstraaten B, Staguet M, et al. Reporting results of cancer treatment. Cancer 1981;47:207-214.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
19. Peto R, Peto J. Asymptomatically efficient rank invariant procedures. J R Stat Soc 1972;135:185-198.
20. Cox DR. Regression models and life tables. J R Stat Soc 1972;34: 187-220.
21. Nissen NI, Ersboll J, Hansen HA, et al. A randomised study of radiotherapy plus chemotherapy in stage I and II non-Hodgkin's lymphomas. Cancer 1983;52:1-7.
22. Bremnes RM, Bremnes Y, Donnem T. High-grade non-Hodgkin's lymphoma treated in northern Norway - treatment, outcome, and prognostic factors. Acta Oncol 1999;38:117-124.
23. Hahn JS, Lee S, Chong SY, et al. Eight-year experience of malignant lymphoma - survival and prognostic factors. Yonsei Med J 1997;35:270-284.
24. Bitran JD, Kinzie J, Sweet DL, et al. Survival of patients with localised histiocytic lymphoma. Cancer 1977;39:342-346.
25. Cabanillas F, Burke JJ. Prognostic factors in adults with advanced non-Hodgkin's lymphoma (NHL). Proc Am Soc Clin Oncol 1976; 17:256.
26. Richards MA, Gregory WM, Hall PA, et al. Management of localized non-Hodgkin's lymphoma: the experience at St. Bartholomew's Hospital 1972-1985. Hematol Oncol 1989;7:1-18.
27. Ezzat A, Berry J, Jamshed A, et al. Stage I and II aggressive non-Hodgkin's lymphomas. The predictive value of the international prognostic index. Proc Annu Meet Am Soc Clin Oncol 1996;15:1325.
28. Mackintosh JF, Cowan RA, Jones M, et al. Prognostic factors in stage I and II high and intermediate grade non-Hodgkin's lymphoma. Eur J Cancer Clin Oncol 1988;24:1617-1612.